U.S. Markets closed

Global Cord Blood Corporation (CO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
3.8200+0.1900 (+5.23%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close3.6300
Open3.6800
Bid3.8200 x 900
Ask3.8200 x 1100
Day's Range3.6500 - 3.8200
52 Week Range2.5400 - 5.7900
Volume223,769
Avg. Volume220,932
Market Cap464.325M
Beta (5Y Monthly)0.40
PE Ratio (TTM)13.04
EPS (TTM)0.2930
Earnings DateJun 30, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 31, 2018
1y Target Est15.00
  • Global Cord Blood Corporation Files Its Annual Report on Form 20-F
    PR Newswire

    Global Cord Blood Corporation Files Its Annual Report on Form 20-F

    Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. The filed Form 20-F includes audited financial statements for the fiscal year ended March 31, 2020. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission's website at http://www.sec.gov and also be found at the Investor Relations section of GCBC's website at http://ir.globalcordbloodcorp.com.

  • Thomson Reuters StreetEvents

    Edited Transcript of CO earnings conference call or presentation 30-Jun-20 12:00pm GMT

    Q4 2020 Global Cord Blood Corp Earnings Call

  • Do Hedge Funds Like Global Cord Blood Corp (CO)?
    Insider Monkey

    Do Hedge Funds Like Global Cord Blood Corp (CO)?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]